74 related articles for article (PubMed ID: 30035127)
1. T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.
Dong X; Jiang Y; Liu J; Liu Z; Gao T; An G; Wen T
Biomed Res Int; 2018; 2018():9532389. PubMed ID: 30035127
[TBL] [Abstract][Full Text] [Related]
2. Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells.
Thomas D; Sagar S; Caffrey T; Grandgenett PM; Radhakrishnan P
J Cell Mol Med; 2019 Oct; 23(10):6885-6896. PubMed ID: 31389667
[TBL] [Abstract][Full Text] [Related]
3. Tn antigen promotes breast cancer metastasis via impairment of CASC4.
Li R; Dong X; Chen S; Tan J; Chen X; Liu J; Wen T; Ru X
Cell Biol Int; 2023 Nov; 47(11):1854-1867. PubMed ID: 37493437
[TBL] [Abstract][Full Text] [Related]
4. TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells.
Kappel S; Stokłosa P; Hauert B; Ross-Kaschitza D; Borgström A; Baur R; Galván JA; Zlobec I; Peinelt C
Mol Oncol; 2019 Nov; 13(11):2393-2405. PubMed ID: 31441200
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylation.
Rømer TB; Khoder-Agha F; Aasted MKM; de Haan N; Horn S; Dylander A; Zhang T; Pallesen EMH; Dabelsteen S; Wuhrer M; Høgsbro CF; Thomsen EA; Mikkelsen JG; Wandall HH
Glycobiology; 2023 Oct; 33(9):700-714. PubMed ID: 36648436
[TBL] [Abstract][Full Text] [Related]
6. Production of CA125 with Tn-antigens using a glycosylphosphatidylinositol anchoring system.
Tang YH; Leng JX; Yang G; Gao XD; Liu YS; Fujita M
J Biochem; 2024 Feb; ():. PubMed ID: 38382634
[TBL] [Abstract][Full Text] [Related]
7. A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion.
Valoskova K; Biebl J; Roblek M; Emtenani S; Gyoergy A; Misova M; Ratheesh A; Reis-Rodrigues P; Shkarina K; Larsen ISB; Vakhrushev SY; Clausen H; Siekhaus DE
Elife; 2019 Mar; 8():. PubMed ID: 30910009
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression.
Tian H; Yu JL; Chu X; Guan Q; Liu J; Liu Y
Front Oncol; 2024; 14():1389713. PubMed ID: 38699634
[TBL] [Abstract][Full Text] [Related]
9. Role of Post-Translational Modifications in Colorectal Cancer Metastasis.
Peng N; Liu J; Hai S; Liu Y; Zhao H; Liu W
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339403
[TBL] [Abstract][Full Text] [Related]
10. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.
Lodewijk I; Dueñas M; Paramio JM; Rubio C
Front Immunol; 2023; 14():1272681. PubMed ID: 37854601
[TBL] [Abstract][Full Text] [Related]
11. ST6GALNAC1 promotes the invasion and migration of breast cancer cells via the EMT pathway.
Luo Y; Cao H; Lei C; Liu J
Genes Genomics; 2023 Nov; 45(11):1367-1376. PubMed ID: 37747641
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor O-glycosylation modulates cancer-immune-cell crosstalk and enhances anti-PD-1 immunotherapy in head and neck cancer.
Lin MC; Chuang YT; Wu HY; Hsu CL; Lin NY; Huang MC; Lou PJ
Mol Oncol; 2024 Feb; 18(2):350-368. PubMed ID: 37452653
[TBL] [Abstract][Full Text] [Related]
13. Bittersweet Sugars: How Unusual Glycan Structures May Connect Epithelial-to-Mesenchymal Transition and Multidrug Resistance in Cancer.
Fonseca LMD; Diniz-Lima I; da Costa Santos MAR; Franklim TN; da Costa KM; Santos ACD; Morrot A; Decote-Ricardo D; Valente RDC; Freire-de-Lima CG; Dos Reis JS; Freire-de-Lima L
Medicines (Basel); 2023 Jun; 10(6):. PubMed ID: 37367731
[TBL] [Abstract][Full Text] [Related]
14. Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn
Hu W; Ding R; Wang M; Huang P; Wei X; Hu X; Hu T
Stem Cell Res Ther; 2023 May; 14(1):145. PubMed ID: 37237420
[TBL] [Abstract][Full Text] [Related]
15. Association of Glycosylation-Related Genes with Different Patterns of Immune Profiles and Prognosis in Cervical Cancer.
Jing W; Zhang R; Chen X; Zhang X; Qiu J
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983711
[TBL] [Abstract][Full Text] [Related]
16. The Blessed Union of Glycobiology and Immunology: A Marriage That Worked.
Dos Reis JS; Diniz-Lima I; Santos MARDC; Barcelos PM; da Costa KM; Valente RDC; Chaves LS; de Campos LP; Dos Santos AC; Correia de Lima RG; Decote-Ricardo D; Morrot A; Previato JO; Mendonça-Previato L; Freire-de-Lima CG; Fonseca LMD; Freire-de-Lima L
Medicines (Basel); 2023 Jan; 10(2):. PubMed ID: 36827215
[TBL] [Abstract][Full Text] [Related]
17. A Sweet Warning: Mucin-Type O-Glycans in Cancer.
Zhang Y; Sun L; Lei C; Li W; Han J; Zhang J; Zhang Y
Cells; 2022 Nov; 11(22):. PubMed ID: 36429094
[TBL] [Abstract][Full Text] [Related]
18. SLC35A2 Deficiency Promotes an Epithelial-to-Mesenchymal Transition-like Phenotype in Madin-Darby Canine Kidney Cells.
Kot M; Mazurkiewicz E; Wiktor M; Wiertelak W; Mazur AJ; Rahalevich A; Olczak M; Maszczak-Seneczko D
Cells; 2022 Jul; 11(15):. PubMed ID: 35892570
[TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.
Khiaowichit J; Talabnin C; Dechsukhum C; Silsirivanit A; Talabnin K
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207462
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
